| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 71IA9S35AJ |
| InChI Key | WUWDLXZGHZSWQZ-WQLSENKSSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C15H14N2O |
| Molecular Weight | 238.29 |
| AlogP | 3.12 |
| Hydrogen Bond Acceptor | 1.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 44.89 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 18.0 |
| Primary Target | |
|---|---|
| fms related receptor tyrosine kinase 1 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Kinase
Protein Kinase
TKL protein kinase group
TKL protein kinase STKR family
TKL protein kinase STKR Type 1 subfamily
|
- | 1200-1810 | - | - | - | |
|
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase Abl family
|
- | 11000 | - | - | - | |
|
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase FGFR family
|
- | 4200-50000 | - | - | 87 | |
|
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase PDGFR family
|
- | 68-37900 | - | - | - | |
|
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase Ret family
|
- | 170 | - | - | - | |
|
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase Src family
|
- | 16400 | - | - | - | |
|
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase Syk family
|
- | 20700 | - | - | - | |
|
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase VEGFR family
|
- | 13-12900 | - | - | 40-40 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
| Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Sarcoma | 2 | D012509 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Carcinoma, Renal Cell | 2 | D002292 | ClinicalTrials |
| Mesothelioma | 2 | D008654 | ClinicalTrials |
| Kidney Neoplasms | 2 | D007680 | ClinicalTrials |
| Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Rectal Neoplasms | 1 | D012004 | ClinicalTrials |
| Breast Neoplasms | 1 | D001943 | ClinicalTrials |
| Colonic Neoplasms | 1 | D003110 | ClinicalTrials |
| Head and Neck Neoplasms | 1 | D006258 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Central Nervous System Neoplasms | 1 | D016543 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 194413-58-6 |
| ChEBI | 91083 |
| ChEMBL | CHEMBL276711 |
| DrugBank | DB06436 |
| FDA SRS | 71IA9S35AJ |
| Guide to Pharmacology | 5056 |
| PDB | X2M |
| PubChem | 5329098 |
| SureChEMBL | SCHEMBL19571 |
| ZINC | ZINC000012410091 |